
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Childhood apraxia of speech (CAS) presents a significant clinical challenge in pediatric neurodevelopmental care. Consequently, understanding its prevalence and its relationship with other disorders like autism is essential for early intervention. A recent comprehensive study analyzed electronic medical records (EMR) from a large pediatric hospital to clarify these figures. Researchers evaluated 7,550 children aged 24 to 48 months who received treatment for various language and articulation concerns between 2016 and 2022.
The results indicate that childhood apraxia of speech has a prevalence of 2.4% in this clinical cohort. Moreover, the study explored the comorbidity with autism spectrum disorder (ASD). While nearly 20% of the children in the sample had an ASD diagnosis, only 1.3% of those with ASD also had a comorbid diagnosis of apraxia. This finding suggests that while the link between the two exists, it may not be as frequent as some previous smaller studies suggested. Furthermore, the analysis investigated several other co-occurring conditions, including phonological and mixed expressive-receptive language disorders.
Interestingly, the study found that no specific language disorder acted as a positive significant predictor for a CAS diagnosis. Therefore, clinicians must maintain a high level of diagnostic vigilance for motor speech symptoms regardless of the child\'s broader language profile. Specifically, these findings align with earlier literature while providing a more precise quantification within an outpatient hospital setting. Ultimately, accurate identification of motor speech impairment remains vital for tailoring specialized speech-language therapy.
Based on a large-scale electronic medical record analysis, the prevalence of childhood apraxia of speech is approximately 2.4% among children seeking outpatient speech and language services.
Recent data shows that approximately 1.3% of children with autism spectrum disorder also have a comorbid diagnosis of apraxia. While the association exists, it is less frequent than previously estimated in some clinical cohorts.
The study found that common language disorders, such as phonological or mixed expressive-receptive disorders, were not significant predictors of apraxia, highlighting the need for specialized motor speech assessments.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Nealon K et al. A Preliminary Investigation of the Prevalence of Motor Speech Impairment Within a Pediatric Outpatient Clinical Setting. Am J Speech Lang Pathol. 2026 May 07. doi: 10.1044/2026_AJSLP-25-00564. PMID: 42096720.
American Speech-Language-Hearing Association (ASHA). Childhood Apraxia of Speech. Available from: https://www.asha.org/public/speech/disorders/childhood-apraxia-of-speech/
Tierney C, et al. Prevalence of Childhood Apraxia of Speech in Children with Autism. J Dev Behav Pediatr. 2015;36(2):117-20.

A study of 7,550 pediatric records found a 2.4% prevalence of Childhood Apraxia of Speech (CAS) and explored its 1.3% comorbidity rate with ASD....
2 weeks back

Stanford scientists cured Type 1 diabetes in mice by transplanting stem and islet cells under a gentle, low-radiation protocol to reset the immune system....
Today

The SRS 2024 report highlights a decline in India's infant mortality rate to 24, though severe state-level disparities and neonatal care gaps persist....
Today

New registry data shows that a lower estimated glucose disposal rate (eGDR), a proxy for insulin resistance, significantly increases the risk of first MI....
Today

Researchers find that FLNB and TTC26 regulate ciliary Hedgehog signaling to maintain intervertebral disc matrix and prevent adolescent idiopathic scoliosis....
Today

Semaglutide significantly reduces body weight and HbA1c in patients with schizophrenia spectrum disorders, according to a 2026 systematic review and meta-an...
Today